Item 5.02. Departure of Directors or Certain
Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Departure of Chief Financial Officer
On May 23, 2022, John F. Glenn notified Ekso Bionics Holdings, Inc.
(the “Company”) of his decision to resign from his position as the Company’s Chief Financial Officer, effective June
17, 2022, in connection with his retention as an employee at another public company. Mr. Glenn’s resignation is not the result of
any dispute or disagreement with the Company including any matters relating to the Company’s accounting practices or financial reporting.
Appointment of Interim Chief Financial Officer
On May 25, 2022, the Company’s board of directors (the “Board”)
approved the appointment of Jerome Wong as Interim Chief Financial Officer, effective upon Mr. Glenn’s departure. Mr. Wong, 48,
has served as the Company’s Controller since May 2017 and brings more than 20 years of experience in finance, accounting and strategy
to this role focusing on high technology and life sciences in public companies. Previously, Mr. Wong worked for over a decade from 2009
through 2016 as a corporate controller or assistant corporate controller to companies in the high technology and life sciences industries
including ABM Industries, Inc. from July 2006 through September 2008, XOMA Corporation from July 2009 through October 2014 and Pattern
Energy Group Inc. from October 2014 to December 2015. Mr. Wong is a Canadian Chartered Professional Accountant and has a B.A. in Finance
and Accounting from The University of British Columbia.
Mr. Wong currently receives a salary of $212,000 under his offer letter
with the Company dated May 22, 2017, and the Board has approved an increase in his salary to $265,000 effective June 17, 2022. In addition,
under his offer letter, Mr. Wong is eligible to receive an annual discretionary bonus with a target bonus amount now set by the Board
at 50% of his annual base salary in connection with his promotion to Interim Chief Financial Officer, all or a portion of which, if any,
may be based on the achievement of certain operational, financial or other milestones established by the Board. The Board also approved
an award of restricted stock units to Mr. Wong, to be granted under the Company’s Amended
and Restated 2014 Equity Incentive Plan (the “EIP”) effective June 17, 2022, for a number of shares to be equal to
$150,000 divided by the closing price of the Company’s common stock as quoted on Nasdaq on June 17, 2022, which will vest in thirds
on each annual anniversary of June 17, 2022, subject to his continued employment with the Company.
Mr. Wong is also entitled to receive perquisites and other fringe benefits
that may be provided to, and will be eligible to participate in any other bonus or incentive program established by us, for our executives.
Mr. Wong and his dependents will also be entitled to participate in any of our employee benefit plans subject to the same terms and conditions
applicable to other employees. Mr. Wong is entitled to be reimbursed for all reasonable travel, entertainment and other expenses incurred
by him for the purpose of conducting our business, in accordance with our policies.
There are no arrangements or understandings between Mr. Wong and any
other person pursuant to which Mr. Wong was appointed to serve as Interim Chief Financial Officer of the Company. There are no family
relationships between Mr. Wong and any director or executive officer of the Company, and Mr. Wong does not have any direct or indirect
material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.
On May 26, 2022, the Company issued a press release announcing the
departure of Mr. Glenn and appointment of Mr. Wong. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on
Form 8-K.
Long Term Incentive Award
On May 26, 2022, the Compensation Committee of the Board approved an
award of 300,000 restricted stock units under the EIP to Scott Davis, the Company’s President and Chief Operating Officer, in respect
of his promotion to that role on January 21, 2022. The award vests in even thirds on each annual anniversary of January 21, 2022, subject
to his continued employment with the Company.